Expression of the tumor-associated gene MN: A potential biomarker for human renal cell carcinoma

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2362-2365

  McKiernan, James M ^a   Buttyan, Ralph ^a   Bander, Neil H ^b   Stifelman, Michael D ^a   Katz, Aaron E ^a   Chen, Min Wei ^a   Olsson, Carl A ^a   Sawczuk, Ihor S ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; GENE PRODUCT; MEMBRANE ANTIGEN; RNA; TUMOR ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; FEMALE; HELA CELLS; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030984803     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Partin, A. W., and Oesterling, J. E. The clinical usefulness of prostate-specific antigen: update 1994. J. Urol., 152: 1358-1368, 1994.
2. Wu, A., Ben-Ezra, J., and Colombero, A. Detection of micrometastasis in breast cancer by the polymerase chain reaction. Lab. Invest., 62: 109A, 1990.
3. Van Dongen, G. A., Biakenhoff, R. M., Van Brink, C. T., Van Guy, F. B., de Bree, R., Quak, J. J., and Snow, G. B. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. Anticancer Res., 16: 2409-2413, 1996.
4. Stevens, G. L., Scheer, W. D., and Levine, E. A. Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiol., Biomarkers & Prev., 5: 293-296, 1996.
5. Miller, W. H., Levine, K., DeBlasio, A., Frankel, S. R., Dmitrovsky, E., and Warrell, R. P., Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcriptase polymerase chain reaction assay for the PML/RAR-α fusion mRNA. Blood, 82: 1689, 1993.
6. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
7. Burchill, S. A., Bradbury, M. F., Pittmann, K., Southgate, J., Smith, B., and Selby, P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br. J. Cancer, 71: 278-281, 1995.
8. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics 1996. CA, Cancer J. Clin., 46: 5, 1996.
9. Maldazys, J. D., and DeKernion, J. B. Prognostic factors in metastatic renal cell carcinoma. J. Urol., 136: 376-379, 1986.
10. Der, C. J., and Stanbridge, E. J. A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell, 26: 429-438, 1981.
11. Liao, S. Y., Brewer, C., Zavada, J., Pastorek, J., Pastorekova, S., Manetta, A., Berman, M., Disaia, P. J., and Stanbridge, E. J. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am. J. Pathol., 145: 598-609, 1994.
12. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zativicova, M., Liao, S., Portell, D., Stanbridge, E. J., Zavada, J., Burny, A., and Kettmann, R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene, 9: 2877-2887, 1994.
13. Ebert, T., Bander, N. H., Finstad, C. L., Ramsawak, R. D., and Old, L. J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res., 50: 5531-5536, 1990.
14. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
15. Oosterwijk, E., Ruiter, D. J., Hoedemaker, P. J., Pauwels, E. K., Jonas, U., Zwartendijk, J., and Warnaar, S. O. Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent in normal kidney. Int. J. Cancer, 38: 489-494, 1986.
16. Bander, N. H., Finstad, C. L., Cordon-Cardo, C., Ramsawak, R. D., Vaughan, E. D., Jr., Whitmore, W. F., Jr., Oettgen, H. F., Melamed, M. R., and Old, L. J. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res., 4: 6774-6780, 1989.
17. Ljungberg, B., Rasmusen, T., and Glankuist, K. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Eur. Urol., 21: 160-163, 1992.
18. Partin, A. W., Criley, S. R., Steiner, M. S., Hsieh, K., Simons, J. W., Lumadue, J., Carter, H. B., and Marshall, F. F. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology, 45: 211-217, 1995.
19. Gross, A. J., Michl, V. H., Bornhoft, G., and Diechmann, K. P. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma? Eur. Urol., 24: 397-399, 1993.
20. Kusama, K., Asano, M., Moro, I., Sekine, T., Kazikoe, T., Tobisu, K., and Kishi, K. Tumor markers in human renal cell carcinoma. Tumor Biol., 12: 189-197, 1991.
21. Opavsky, R., Pastorekova, S., Zelnik, V., Gibadulinova, A., Stanbridge, E. J., Zavada, J., Kettmann, R., and Pastorek, J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics, 33: 480-487, 1996.
22. Oosterwijk, E., de Weijert, M., von Bokhoven, A., Brakenhoff, R. H., Peelen, W. P., and Debruyne, F. M. J. Molecular characterization of the renal cell carcinoma-associated antigen G250. J. Urol., 155: 925, 1996.